Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-27 @ 4:15 AM
Study NCT ID:
NCT01685359
Status:
COMPLETED
Last Update Posted:
2022-10-28
First Post:
2012-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant
Sponsor:
Azidus Brasil
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2013-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-26
First Submit QC Date:
None
Study First Post Date:
2012-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-26
Last Update Post Date:
2022-10-28
Last Update Post Date Type:
ACTUAL